[Therapy of Lesniowski-Crohn disease of the upper part of the gastrointestinal tract].

The treatment of a form of Lesniowski-Crohn disease (L-CD) which occurs in the upper part of the gastrointestinal tract (GI) in principle is similar to that which is used if other parts of the GI tract are involved in L-CD, however with certain modifications, and these problems are discussed in this paper. The treatment is based on 5-aminosalicylic acid (5-ASA), glucocorticosteroids, antibiotics and immunosuppressive drugs. For patients in whom the conventional therapy doesn't give expected results, the advent of infliximab (biologic agents) has greatly improved treatment possibilities of L-CD.

[Leśniowski-Crohn's disease in the upper part of the gastrointestinal tract].

Leśniowski-Crohn's disease (L-CD) includes several clinical and pathological pictures which are manifestations of transmural inflammation. L-CD may affect any portion of the gastrointestinal tract (GI) and in the upper part of GI it has been described in 0.5%-13.